INVO Bioscience (INVO) Competitors $2.55 +0.02 (+0.85%) As of 07/21/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock INVO vs. BTCY, TTOO, DYNT, NAYA, IONM, AFIB, GMVDF, NMRD, MOTS, and UTRSShould you be buying INVO Bioscience stock or one of its competitors? The main competitors of INVO Bioscience include Biotricity (BTCY), T2 Biosystems (TTOO), Dynatronics (DYNT), NAYA Biosciences (NAYA), Assure (IONM), Acutus Medical (AFIB), G Medical Innovations (GMVDF), Nemaura Medical (NMRD), Motus GI (MOTS), and Minerva Surgical (UTRS). These companies are all part of the "surgical & medical instruments" industry. INVO Bioscience vs. Its Competitors Biotricity T2 Biosystems Dynatronics NAYA Biosciences Assure Acutus Medical G Medical Innovations Nemaura Medical Motus GI Minerva Surgical INVO Bioscience (NASDAQ:INVO) and Biotricity (NASDAQ:BTCY) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, risk, analyst recommendations, profitability, earnings, media sentiment, institutional ownership and valuation. Which has more volatility & risk, INVO or BTCY? INVO Bioscience has a beta of 1.43, indicating that its share price is 43% more volatile than the S&P 500. Comparatively, Biotricity has a beta of 1.11, indicating that its share price is 11% more volatile than the S&P 500. Do insiders and institutionals have more ownership in INVO or BTCY? 12.0% of INVO Bioscience shares are owned by institutional investors. Comparatively, 3.9% of Biotricity shares are owned by institutional investors. 3.5% of INVO Bioscience shares are owned by company insiders. Comparatively, 10.1% of Biotricity shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Does the media refer more to INVO or BTCY? In the previous week, Biotricity had 6 more articles in the media than INVO Bioscience. MarketBeat recorded 6 mentions for Biotricity and 0 mentions for INVO Bioscience. Biotricity's average media sentiment score of 0.92 beat INVO Bioscience's score of 0.00 indicating that Biotricity is being referred to more favorably in the news media. Company Overall Sentiment INVO Bioscience Neutral Biotricity Positive Is INVO or BTCY more profitable? Biotricity has a net margin of -80.42% compared to INVO Bioscience's net margin of -122.79%. Company Net Margins Return on Equity Return on Assets INVO Bioscience-122.79% N/A -36.94% Biotricity -80.42%N/A -188.47% Do analysts rate INVO or BTCY? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score INVO Bioscience 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Biotricity 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Which has preferable valuation & earnings, INVO or BTCY? INVO Bioscience has higher earnings, but lower revenue than Biotricity. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioINVO Bioscience$5.77M1.68-$8.03MN/AN/ABiotricity$12.06M1.05-$14.09M-$0.67-0.76 SummaryBiotricity beats INVO Bioscience on 6 of the 11 factors compared between the two stocks. Get INVO Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for INVO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding INVO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart INVO vs. The Competition Export to ExcelMetricINVO BioscienceSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$9.71M$63.98M$5.49B$9.45BDividend YieldN/AN/A4.01%4.03%P/E RatioN/A5.2728.4719.90Price / Sales1.68118.57410.1985.18Price / CashN/A18.4135.9658.29Price / Book-1.247.548.365.67Net Income-$8.03M-$24.96M$3.24B$258.18M7 Day Performance217.99%28.13%3.13%2.81%1 Month Performance109.02%19.66%10.98%13.53%1 Year Performance221.12%72.58%34.54%17.68% INVO Bioscience Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)INVOINVO BioscienceN/A$2.55+0.9%N/A+227.3%$9.71M$5.77M0.0025BTCYBiotricityN/A$0.39-4.5%N/A-39.0%$9.74M$12.06M-0.3640Analyst RevisionGap UpTTOOT2 BiosystemsN/A$0.11-0.9%$5.00+4,251.6%-99.6%$2.42M$7.68M0.00180Upcoming EarningsDYNTDynatronicsN/A$0.09-7.4%N/A-66.2%$935K$33.60M-0.11200Gap DownNAYANAYA BiosciencesN/A$0.78-5.4%$24.00+2,993.6%N/A$517K$6.23M0.0010High Trading VolumeIONMAssureN/A$0.03flatN/A-98.3%$91K$149K0.00130AFIBAcutus MedicalN/A$0.00+10.0%N/A-96.1%$66K$7.16M0.00340Gap DownGMVDFG Medical InnovationsN/A$0.00flatN/AN/A$26K$4.42M0.0072NMRDNemaura Medical1.2233 of 5 stars$0.00flatN/A-99.7%$4K$3.02K0.0040MOTSMotus GIN/A$0.00flatN/A-99.9%$2K$319K0.0030UTRSMinerva SurgicalN/AN/AN/AN/A$1K$51.69M0.00160 Related Companies and Tools Related Companies Biotricity Competitors T2 Biosystems Competitors Dynatronics Competitors NAYA Biosciences Competitors Assure Competitors Acutus Medical Competitors G Medical Innovations Competitors Nemaura Medical Competitors Motus GI Competitors Minerva Surgical Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:INVO) was last updated on 7/23/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?Bitcoin is breaking out — and one state just created a Strategic Crypto Reserve. James Altucher says this m...Paradigm Press | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding INVO Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share INVO Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free INVO Stock Alerts